126 related articles for article (PubMed ID: 24517070)
1. [Effect of shenshuning recipe on the extracellular matrix accumulation of the peritoneal fibrosis rats].
Yang HT; Shang YC; Cao SL; Dou YT; Huang Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1683-9. PubMed ID: 24517070
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Shensu II Recipe on the expressions of transforming growth factor-beta1, and plasminogen activator inhibitor-1 in the focal segmental glomerulosclerosis rats].
Dou YT; Yang HT; Cao SL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Nov; 31(11):1531-7. PubMed ID: 22303720
[TBL] [Abstract][Full Text] [Related]
3. [Intervention of modified Shenling Baizhu San on peritoneal fibrosis induced by peritoneal dialysate with different sugar concentration in rats].
Lyu Y; Chen X; Zhang L; Shang L; Wang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):875-880. PubMed ID: 37593870
[TBL] [Abstract][Full Text] [Related]
4. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Hong M; Nie Z; Chen Z; Yu X; Bao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
[TBL] [Abstract][Full Text] [Related]
5. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
6. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
[TBL] [Abstract][Full Text] [Related]
7. [Protective effects and mechanisms of xin'ganbao capsule on STZ induced early kidney injury in diabetic rats].
Gao J; Fan L; Liu MJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Apr; 32(4):530-6. PubMed ID: 22803438
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats.
Li L; Shen N; Wang N; Wang W; Tang Q; Du X; Carrero JJ; Wang K; Deng Y; Li Z; Lin H; Wu T
Kidney Int; 2018 Jun; 93(6):1384-1396. PubMed ID: 29571940
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model.
Chunming J; Miao Z; Cheng S; Nana T; Wei Z; Dongwei C; Yuan F
Ren Fail; 2011; 33(3):355-62. PubMed ID: 21401363
[TBL] [Abstract][Full Text] [Related]
11. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
12. [The role of TGF-beta1/Smads in the development of peritoneal fibrosis induced by high glucose peritoneal dialysate and LPS].
Dou XR; Yu XQ; Li XY; Chen WF; Hao WK; Jia ZJ; Peng WX; Wang X; Yin PD; Wang WJ; Zheng ZH
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2613-8. PubMed ID: 16321321
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin (LMWH) improves peritoneal function and inhibits peritoneal fibrosis possibly through suppression of HIF-1α, VEGF and TGF-β1.
Li J; Guo ZY; Gao XH; Bian Q; Jia M; Lai XL; Wang TY; Bian XL; Wang HY
PLoS One; 2015; 10(2):e0118481. PubMed ID: 25723475
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.
Kinashi H; Ito Y; Mizuno M; Suzuki Y; Terabayashi T; Nagura F; Hattori R; Matsukawa Y; Mizuno T; Noda Y; Nishimura H; Nishio R; Maruyama S; Imai E; Matsuo S; Takei Y
J Am Soc Nephrol; 2013 Oct; 24(10):1627-42. PubMed ID: 23990681
[TBL] [Abstract][Full Text] [Related]
15. Pyrrole-imidazole polyamide targeting transforming growth factor β1 ameliorates encapsulating peritoneal sclerosis.
Serie K; Fukuda N; Nakai S; Matsuda H; Maruyama T; Murayama Y; Omata S
Perit Dial Int; 2012; 32(4):462-72. PubMed ID: 22215658
[TBL] [Abstract][Full Text] [Related]
16. [Effects of extraction of Angelicae sinensis and Astragalus mongholicus on the peritoneal structure, functions and TGF-β
Du LD; Wu GT; Wang FL; Zhang Y; Ren Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Jun; 32(6):563-566. PubMed ID: 29926628
[TBL] [Abstract][Full Text] [Related]
17. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
18. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
[TBL] [Abstract][Full Text] [Related]
19. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
20. Impact of rapamycin on peritoneal fibrosis and transport function.
Xu T; Xie JY; Wang WM; Ren H; Chen N
Blood Purif; 2012; 34(1):48-57. PubMed ID: 22922738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]